

Aspen Pharmacare Holdings Limited (APNHY) Shareholder/Analyst Call Prepared Remarks Transcript

Aspen Pharmacare Holdings Limited (APNHY) Q2 2026 Earnings Call Transcript

Aspen Pharmacare's unbranded version of Novo Nordisk's popular diabetes drug Ozempic could be registered in Canada in the second or third quarter of this year, the South African pharmacueticals group's CEO said on Tuesday.

Aspen Pharmacare Holdings Limited (APNHY) Discusses Proposed Divestment of APAC Operations Excluding China Transcript

Aspen Pharmacare Holdings Limited (OTCPK:APNHY) Q4 2025 Earnings Call September 4, 2025 2:30 AM EDT Company Participants Sanelisiwe Tonga Stephen Saad - Group CEO & Executive Director Sean Capazorio - Group CFO & Executive Director Presentation Sanelisiwe Tonga Good morning, ladies and gentlemen. A very warm welcome to Aspen's 2025 Annual Results Presentation.

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q2 2025 Results Conference Call March 4, 2025 1:30 AM ET Company Participants Sibongakonke Nkosi - Investor Relations Stephen Saad - Group Chief Executive Officer Sean Capazorio - Group Chief Financial Officer Sibongakonke Nkosi Good morning. A very warm welcome to everyone joining us in person, online for Aspen's 2025 Interim Results Presentation.

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2024 Earnings Conference Call September 4, 2024 2:30 AM ET Company Participants Sibongakonke Nkosi - Investor Relations Stephen Saad - Group Chief Executive Officer & Executive Director Sean Capazorio - Group Chief Financial Officer & Executive Director Conference Call Participants Sibongakonke Nkosi Good morning, everyone. It's good to see you all here today and welcome to Aspen's Full Year Financial Results for the 2024 Period.

Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2023 Results Conference Call August 31, 2023 2:30 AM ET Company Participants Sibongakonke N. - Investor Relations Manager Stephen Saad - Chief Executive Officer Sean Capazorio - Chief Financial Officer Conference Call Participants Christella Muligande - Bateleur Capital Charlie Le Quelenec - Ashburton Mohamed Loonat - Mianzo Asset Management Ken Osei - IFC Junaid Bray - Laurium Capital Nancy Bambo - Excelsia Capital Sibongakonke N.
No recent filings indexed.